Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard L Berkowitz

Showing results (31-40 of 56) with videos related to

Pageof 6
Sort By:
Obstetrics and Gynecology|August 2, 2007
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trialRichard L Berkowitz, Martin L Lesser, Janice G McFarland, et al.
Obstetrics and Gynecology|October 22, 2011
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratificationLuis D Pacheco, Richard L Berkowitz, Kenneth J Moise, et al.
American Journal of Obstetrics and Gynecology|October 12, 2013
The case for an electronic fetal heart rate monitoring credentialing examinationRichard L Berkowitz, Mary E D'Alton, James D Goldberg, et al.
American Journal of Obstetrics and Gynecology|May 25, 2010
Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetusJames B Bussel, Richard L Berkowitz, Crystal Hung, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
American Journal of Obstetrics and Gynecology|May 2, 2016
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Richard L Berkowitz, Cheryl A Vinograd, et al.
Transfusion|September 10, 2016
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Jenny C Jin, Karen C Manotas, et al.
Obstetrics and Gynecology|December 2, 2004
First-trimester nasal bone evaluation for aneuploidy in the general populationFergal D Malone, Robert H Ball, David A Nyberg, et al.
American Journal of Obstetrics and Gynecology|March 26, 2004
Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening studyJoshua L Weiss, Fergal D Malone, John Vidaver, et al.
American Journal of Obstetrics and Gynecology|September 5, 2006
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?Christine H Comstock, Fergal D Malone, Robert H Ball, et al.
Pageof 6

Showing results (31-40 of 56) with videos related to

Sort By:
Pageof 6
Obstetrics and Gynecology|August 2, 2007
Antepartum treatment without early cordocentesis for standard-risk alloimmune thrombocytopenia: a randomized controlled trialRichard L Berkowitz, Martin L Lesser, Janice G McFarland, et al.
Obstetrics and Gynecology|October 22, 2011
Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratificationLuis D Pacheco, Richard L Berkowitz, Kenneth J Moise, et al.
American Journal of Obstetrics and Gynecology|October 12, 2013
The case for an electronic fetal heart rate monitoring credentialing examinationRichard L Berkowitz, Mary E D'Alton, James D Goldberg, et al.
American Journal of Obstetrics and Gynecology|May 25, 2010
Intracranial hemorrhage in alloimmune thrombocytopenia: stratified management to prevent recurrence in the subsequent affected fetusJames B Bussel, Richard L Berkowitz, Crystal Hung, et al.
American Journal of Hematology|May 7, 2019
Maternal sensitization occurs before delivery in severe cases of fetal alloimmune thrombocytopeniaJenny C Jin, Madhavi M Lakkaraja, Polina Ferd, et al.
American Journal of Obstetrics and Gynecology|May 2, 2016
Omission of fetal sampling in treatment of subsequent pregnancies in fetal-neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Richard L Berkowitz, Cheryl A Vinograd, et al.
Transfusion|September 10, 2016
Blood group A mothers are more likely to develop anemia during antenatal intravenous immunoglobulin treatment of fetal and neonatal alloimmune thrombocytopeniaMadhavi Lakkaraja, Jenny C Jin, Karen C Manotas, et al.
Obstetrics and Gynecology|December 2, 2004
First-trimester nasal bone evaluation for aneuploidy in the general populationFergal D Malone, Robert H Ball, David A Nyberg, et al.
American Journal of Obstetrics and Gynecology|March 26, 2004
Threatened abortion: A risk factor for poor pregnancy outcome, a population-based screening studyJoshua L Weiss, Fergal D Malone, John Vidaver, et al.
American Journal of Obstetrics and Gynecology|September 5, 2006
Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening?Christine H Comstock, Fergal D Malone, Robert H Ball, et al.
Pageof 6